Corporate Governance

Health Canada’s updated requirements for drug and medical device recalls
In December, Health Canada published regulations amending the current guidance pertaining to recalls of food, drugs and medical devices.
Pharma-tariffs
If the U.S. goes ahead with its tariffs, we can expect tariffs on drugs and Canada to retaliate with similar measures, warns pharmacy industry expert Bertrand Bolduc.

Alberta puts contracts on hold amid allegations of corruption in private surgeries

Alberta’s front-line health provider says it will stop awarding contracts to firms at the centre of an auditor’s investigation into what the Opposition NDP calls unprecedented allegations of corruption.
Alberta NDP demands probe into allegations of sweeping corruption in health contracts

Alberta NDP Leader Naheed Nenshi is calling for four investigations and for Premier Danielle Smith to answer questions on what he calls unprecedented allegations of high-level corruption into medical purchases and surgery contracts.
Canadian researchers who rely on U.S. medical grants say some projects at risk even as funding resumes

U.S. President Donald Trump made a series of executive orders that week, which also included ending federal spending on diversity, equity, and inclusion (DEI) programs.
Provinces worry over healthcare recruitment as federal government slashes skilled immigration numbers

The federal government is cutting spaces for the provincial nominee program in half for all provinces and territories that offer the program.
How Trump’s tariffs could affect Canada’s drug manufacturing landscape

Expanded tariffs spell drug shortages and higher prices for Canadians.
Drug company Apotex acquires CanPrev, a provider of vitamins and supplements

CanPrev owns the CanPrev, Cyto-Matrix and Orange Naturals brands.
Alberta government overhauls board of health authority, appoints administrator

Alberta’s government says it has dismantled the board of Alberta Health Services—for the second time in nearly as many years.
Ottawa defers effective date of capital gains changes to 2026

The deferral moves back the implementation of the change from June 25, 2024 to January 1, 2026.

Health Canada’s updated requirements for drug and medical device recalls

Pharma-tariffs

Alberta puts contracts on hold amid allegations of corruption in private surgeries

Alberta NDP demands probe into allegations of sweeping corruption in health contracts

Canadian researchers who rely on U.S. medical grants say some projects at risk even as funding resumes

Provinces worry over healthcare recruitment as federal government slashes skilled immigration numbers

How Trump’s tariffs could affect Canada’s drug manufacturing landscape

Drug company Apotex acquires CanPrev, a provider of vitamins and supplements

Alberta government overhauls board of health authority, appoints administrator

Ottawa defers effective date of capital gains changes to 2026